Literature DB >> 19769452

Adverse effects of medications commonly used in the treatment of migraine.

Chad A Whyte1, Stewart J Tepper.   

Abstract

The classes of medications for migraine treatment are numerous and include ergots, triptans, NSAIDs, antidepressants, anti-epilepsy drugs, antihypertensives and natural supplements. Physicians need to be aware not only of medication efficacy but also of tolerability and safety. Side effects of these drugs can sometimes be beneficial, as migraineurs frequently have comorbid conditions. For example, those with insomnia can benefit from use of a tricyclic antidepressant that is effective in preventing migraine. However, these same coexistent conditions can be worsened by migraine medication or be contraindicated and multiple medications prescribed for several conditions can result in drug-drug interactions. This article reviews adverse events associated with migraine and medications, and their implications in clinical treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19769452     DOI: 10.1586/ern.09.47

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  9 in total

1.  The Paramedian Forehead Flap: A Retrospective Clinical Model for Understanding the Connection Between Supraorbital and Supratrochlear Nerve Pathology and Headaches.

Authors:  Eva B Niklinska; Juan M Colazo; James Randall Patrinely; Brian C Drolet; Salam A Kassis
Journal:  Plast Surg (Oakv)       Date:  2021-04-27       Impact factor: 0.558

Review 2.  Gepants - a long way to cure: a narrative review.

Authors:  Claudia Altamura; Nicoletta Brunelli; Marilena Marcosano; Luisa Fofi; Fabrizio Vernieri
Journal:  Neurol Sci       Date:  2022-06-02       Impact factor: 3.830

3.  Preventive pharmacologic treatments for episodic migraine in adults.

Authors:  Tatyana A Shamliyan; Jae-Young Choi; Rema Ramakrishnan; Jennifer Biggs Miller; Shi-Yi Wang; Frederick R Taylor; Robert L Kane
Journal:  J Gen Intern Med       Date:  2013-04-17       Impact factor: 5.128

4.  A sixteen-week three-armed, randomized, controlled trial investigating clinical and biochemical effects of targeted alterations in dietary linoleic acid and n-3 EPA+DHA in adults with episodic migraine: Study protocol.

Authors:  John Douglas Mann; Keturah R Faurot; Beth MacIntosh; Olafur S Palsson; Chirayath M Suchindran; Susan Ann Gaylord; Chanee Lynch; Angela Johnston; Kristen Maiden; David A Barrow; Joseph R Hibbeln; Christopher E Ramsden
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2017-11-16       Impact factor: 4.006

5.  The Effectiveness of Scutellaria baicalensis on Migraine: Implications from Clinical Use and Experimental Proof.

Authors:  Chung-Chih Liao; Ke-Ru Liao; Cheng-Li Lin; Jung-Miao Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-01-06       Impact factor: 2.629

Review 6.  A Systematic Review and Meta-Analysis on the Efficacy of Repeated Transcranial Direct Current Stimulation for Migraine.

Authors:  Guoshuai Cai; Zhu Xia; X Michelle Androulakis; Leigh Charvet; Feifei Xiao; Abhishek Datta
Journal:  J Pain Res       Date:  2021-04-27       Impact factor: 3.133

7.  Eptinezumab for migraine prevention in patients 50 years or older.

Authors:  Vincent Martin; Cristina Tassorelli; Anders Ettrup; Joe Hirman; Roger Cady
Journal:  Acta Neurol Scand       Date:  2022-02-26       Impact factor: 3.915

8.  Radiofrequency Ablation of Pericranial Nerves for Treating Headache Conditions: A Promising Option for Patients.

Authors:  Alaa Abd-Elsayed; Laura Kreuger; Shawna Wheeler; Janet Robillard; Susanne Seeger; Douglas Dulli
Journal:  Ochsner J       Date:  2018

9.  Italian guidelines for primary headaches: 2012 revised version.

Authors:  Paola Sarchielli; Franco Granella; Maria Pia Prudenzano; Luigi Alberto Pini; Vincenzo Guidetti; Giorgio Bono; Lorenzo Pinessi; Massimo Alessandri; Fabio Antonaci; Marcello Fanciullacci; Anna Ferrari; Mario Guazzelli; Giuseppe Nappi; Grazia Sances; Giorgio Sandrini; Lidia Savi; Cristina Tassorelli; Giorgio Zanchin
Journal:  J Headache Pain       Date:  2012-05       Impact factor: 7.277

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.